Navigation Links
Increased Capacity For Porcine Liver Esterase

ST. LOUIS, June 6 /PRNewswire/ -- Lee Biosolutions, Inc, a worldwide supplier for porcine liver esterase has announced it has increased its capacity to an industrial scale of over 150 million units per batch size.

Lee Biosolutions supplies Porcine Liver Esterase and other stable high purity enzymes and related proteins to major diagnostic companies used in urine tests as an indicator of blood or urine infection. Porcine liver esterase is also used on a large commercial scale as a biocatalyst in the resolution of mixtures of chiral esters by hydrolysis to produce optically active carboxylic acids.

Lee Biosolutions growth for porcine liver esterase is attributed to meeting stringent customer specifications while maintaining consistent high quality products that out perform other manufacturers on the market. Lee Biosolutions scientific team operates with built-in flexibility, is able to respond in a timely manner and has some of the best scientists working in this industry.

According to Lee Biosolutions President Burton Lee, porcine liver esterase demand has increased significantly over the past 12 months. "We operate with one ear constantly tuned to the diagnostic manufacturing and pharmaceutical community," Lee said. "This helps us stay on top of the latest research being conducted on hydrolase enzymes such as porcine liver esterase and gives us the information we need to stay ahead of their demands."

Lee Biosolutions is a leader in the biomarker industry, providing quality products such as (porcine liver esterase) to clinical labs and researchers around the world, developing tomorrow's cures. For more information on porcine esterase and our capabilities go to or contact:

Press Release Contact Information:

Burton Lee


Lee Biosolutions, Inc


This release was issued through WebWire(R). For more information visit

SOURCE Lee Biosolutions, Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis
2. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
3. Nephrologists and Non-Nephrologists Alike Report Increased Attention on Chronic Kidney Disease
4. LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
5. Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
6. Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
7. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
8. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
9. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
10. AMTs Cooperative Research and Development Agreement With NIH to Boost Production Capacity
11. Dragon announces new product launch; increase in annual production output capacity
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
Breaking Biology News(10 mins):